Providers identify knowledge gaps, emotional burden as key barriers to lung cancer treatment readiness

Fifty healthcare providers across the United States were asked a straightforward question: what stops lung cancer patients from being ready for treatment? The answers paint a picture of a system where information exists but understanding does not, where support services are scattered, and where the weight of a cancer diagnosis itself becomes an obstacle to the very care that might save a patient's life.

The study, which combined surveys and interviews with oncology specialists and other lung cancer care providers, identified two critical junctures where patients stumble. The first happens at diagnosis, when doctors present treatment options. Seventy percent of surveyed providers said patients struggle to grasp what those options actually mean. One oncologist described the problem plainly: patients retain roughly ten percent of what is explained during their first visit. Another noted that even when information is technically available, patients frequently cannot hold it in their minds during emotionally overwhelming clinical encounters. The complexity is real—treatment regimens often combine multiple medications and modalities, and explaining how much a given therapy will improve outcomes requires translating probability and medical data into human terms. But the barrier is not merely intellectual. Sixty-eight percent of providers identified emotional distress as a major impediment to decision-making. A new cancer diagnosis, especially one that has already spread, creates a kind of psychological shock that makes it nearly impossible for patients to absorb, evaluate, and choose among treatment paths.

Financial and logistical realities compound this cognitive and emotional burden. Sixty percent of providers reported that financial concerns shape how patients think about their options—insurance restrictions, the cost of diagnostic scans, the simple fact that resources are limited. One provider described a patient unable to access a PET scan because their insurance only covered imaging at a facility in another state. Transportation emerged as perhaps the most concrete barrier: eighty percent of providers cited it as a major obstacle. Patients miss appointments because rides do not materialize. One provider recounted a patient with brain metastases who could no longer drive and missed every scan and every visit because the arranged transportation never showed up.

Once a patient has made a decision and treatment is about to begin, a second set of barriers emerges. Fifty-six percent of providers said patients lack understanding of what the treatment process will actually entail—the logistics, the flow of a treatment day, how long appointments will take, what side effects to expect and how to manage them. Sixty-eight percent of providers identified logistical challenges as obstacles to treatment initiation, and the emotional weight persists. Some patients struggle to accept the diagnosis before treatment even starts. Others experience denial or psychological distress that disrupts their ability to prepare. Fifty-eight percent of providers noted that patients without caregivers or family support face particular difficulty understanding plans and navigating the emotional terrain of treatment initiation. Language barriers compound everything: sixty-two percent of providers identified communication obstacles as significant, particularly for African American, Spanish-speaking, and Asian patients already navigating a healthcare system that feels foreign.

The providers surveyed are not passive observers. Most use in-person consultations (ninety-two percent) and printed educational materials (sixty-two percent) to prepare patients. Some clinics have social workers who arrange transportation, nurses who conduct teaching visits, and systems for proactive outreach when patients miss appointments. Yet these efforts, while valuable, remain inconsistent and often address only the most immediate problems. One-off consultations and printed materials do not reach patients with low health literacy or those from different cultural backgrounds. Educational videos are rarely used. Digital tools, despite their potential, remain largely untapped.

When asked what would help, providers prioritized emotional and psychological support services, logistical support, and more detailed educational materials. But they also emphasized something structural: the need for standardized, phase-specific educational protocols that remain flexible enough to meet patients where they are—accounting for literacy levels, language needs, and cultural context. Several providers mentioned the potential of digital tools to complement in-person education, to help patients understand scans and treatment decisions through visuals, to reinforce information outside clinical visits. Others stressed the importance of patient navigators, dedicated check-in calls, and systems that encourage patients to reach out without fear of bothering their doctors. One provider suggested offering parking vouchers consistently, recognizing that small logistical barriers accumulate into reasons not to show up.

The study reveals a gap between what exists and what patients can actually use. Information is available; comprehension is not. Support services exist in pockets; they are not systematic. The path forward, according to these providers, requires combining structured educational workflows with psychosocial support and accessible supplemental technologies—not as replacements for in-person care, but as reinforcements. It requires training care teams to deliver consistent messages proactively. It requires recognizing that a patient facing a lung cancer diagnosis is not simply a person who needs information. They are someone experiencing cognitive overload, emotional distress, and practical obstacles that together can delay or derail the treatment that might extend their life.